Molecularly Driven, Immune-Based, Maintenance Niraparib and Dostarlimab in Advanced Stage Cholangiocarcinoma

Status: Closed to Accrual

Learn more:

• clinicaltrials.gov: #NCT04895046

Study Contact: studies@hoosiercancer.org; (317) 921-2050.